HealthTech News






Regulatory Trends in AI-enabled SaMDs

FDA authorisations of AI-enabled software as medical devices (SaMDs) have increased significantly. Over 50% of FDA authorisations have occurred since 2022 with the majority (76%)…


GLP-1s’ Challenge to Pharmacovigilance

The international popularity of GLP-1 agonists for weight loss has presented an unforeseen operational challenge for pharma as companies try to keep track of emerging…





HealthTech Thought Leadership


GLP-1s’ Challenge to Pharmacovigilance

The international popularity of GLP-1 agonists for weight loss has presented an unforeseen operational challenge for pharma as companies try to keep track of emerging…





Health Technology Insight


Regulatory Trends in AI-enabled SaMDs

FDA authorisations of AI-enabled software as medical devices (SaMDs) have increased significantly. Over 50% of FDA authorisations have occurred since 2022 with the majority (76%)…